Appili Therapeutics Brief: Also Noted Government Funding Committed to Enable Appili to Advance Its Biodefense Vaccine Candidate ATI-1701 Towards an IND
Appili Therapeutics Brief: Also Noted Government Funding Committed to Enable Appili to Advance Its Biodefense Vaccine Candidate ATI-1701 Towards an IND
Appili Therapeutics 简报：还注意到政府承诺提供资金，使 Appili 能够将其生物防御疫苗候选疫苗 ATI-1701 推向新药研发阶段
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册